Global Enteric Coated and Controlled Release Tablets and Capsules Market

Global Enteric Coated and Controlled Release Tablets and Capsules Market Size, Share, and COVID-19 Impact Analysis, By Type (Tablets, Capsules), By Application (Antibiotic and Antibacterial Drug, Vitamins and Dietary Supplement, Proton Pump Inhibitors, Anti-Inflammatory Drugs, Cardiovascular Therapy Drug, Neurological Drug), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023-2033

Release Date
Sep 2025
Report ID
DAR2425
Pages
210
Report Format

Global Enteric Coated and Controlled Release Tablets and Capsules Market

The Global Enteric Coated and Controlled Release Tablets and Capsules Market Size is Expected to Grow from USD 62.31 Billion in 2023 to USD 124.51 Billion by 2033, Growing at a CAGR of 7.17% during the forecast period 2023 to 2033. The market growth is driven by due to the rising incidence of infectious diseases, hyperacidity, irritable bowel disorders, heart disease, neurological disorders, hormonal and dermatological conditions, and inflammatory diseases worldwide, pharmaceuticals. Moreover, the market for enteric-coated and controlled-release tablets and capsules is growing due to top pharmaceutical companies, which are establishing strong manufacturing facilities. Furthermore, the growing awareness of enteric-coated and controlled-release tablets and capsules is driving a notable increase in the demand for over-the-counter sales of these products.

Global Enteric Coated and Controlled Release Tablets and Capsules Market Segment Size

Major vendors in the Global Enteric Coated and Controlled Release Tablets and Capsules Market

Lonza, CapsulCN International Co., Ltd., NATURAL CAPSULES LIMITED, CapsCanada, Suheung Co., Ltd., GFR Pharma, ACG, Shaanxi Genex Bio-Tech Co., Ltd., GELITA AG, and Colorcon, Almac Group, and others.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Decision Advisor has segmented the enteric coated and controlled release tablets and capsules market based on the below-mentioned segments:

Global Enteric Coated and Controlled Release Tablets and Capsules Market Segment

Global Enteric Coated and Controlled Release Tablets and Capsules Market, By Product Type

  • Tablets
  • Capsules

Global Enteric Coated and Controlled Release Tablets and Capsules Market, By Application

  • Antibiotic and Antibacterial Drug
  • Vitamins and Dietary Supplement
  • Proton Pump Inhibitors
  • Anti-Inflammatory Drugs
  • Cardiovascular Therapy Drug
  • Neurological Drug

Global Enteric Coated and Controlled Release Tablets and Capsules Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Request Table of Contents:

Check Licence

Choose the plan that fits you best: Single User, Multi-User, or Enterprise solutions tailored for your needs.

Report Details

Pages 210 pages
Delivery PDF & Excel, via Email
Language English
Request Discount  

15% Free Customization

Share your requirements

Request Customization  

We Have You Covered

  • 24/7 Analyst Support
  • Clients Across the Globe
  • Tailored Insights
  • Technology Tracking
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Studies
  • Market Overview
  • Market Segmentation
  • Growth Drivers
  • Market Opportunities
  • Regulatory Insights
  • Innovation & Sustainability

Report Details

Pages 210
Delivery PDF & Excel via Email
Language English
Release Sep 2025
Access Download from this page
Request Sample